MicroCHIPS

Michael J. Cima, PhD*
Professor of Materials Science and Engineering, Massachusetts Institute of Technology

Professor Cima is author or co-author of over 190 peer-reviewed scientific publications and 45 patents, and is a recognized expert in the field of materials processing. He is actively involved in materials and engineered systems aimed at improving human health such as treatments for cancer, metabolic diseases, trauma, and urological disorders. Professor Cima's research includes advanced forming technologies for complex macro and micro devices, such as colloid science, MEMS and other micro components for medical devices that are used for drug delivery and diagnostics, as well as high-throughput development methods for formulations of materials and pharmaceutical formulations. He is a co-inventor of MIT's three-dimensional printing process. His research has led to the development of chemically derived epitaxial oxide films for HTSC coated conductors. He and collaborators are developing implantable MEMS devices for unprecedented control in the delivery of pharmaceuticals and implantable diagnostic systems.

William V. Tamborlane, MD, FAAP, FACE
Professor & Chief of Pediatric Endocrinology, Yale University School of Medicine

Dr. Tamborlane is professor and Chief of Pediatric Endocrinology at Yale University, as well as the Deputy Director of the Yale Center for Clinical Investigation. A clinical-research pioneer in diabetes, Dr. Tamborlane conducted early studies that lead to the development of insulin pump therapy, and now directs a multidisciplinary team that cares for more than 1000 children, adolescents and young adults with diabetes. He has been Steering Committee Chair of the Diabetes Research in Children's Network (DirecNet), and is Co-Steering Committee Chair of the Juvenile Diabetes Research Foundation (JDRF) Sensor Network. In 2006 he received the JDRF Award for excellence in clinical research in diabetes. Dr. Tamborlane has served on the FDA’s Endocrine Advisory Board and on the National Board of Directors of the American Diabetes Association. He has published more than 478 original articles, chapters, and reviews in the area of diabetes. He holds a BS and an MD from Georgetown University.

Robert M. Neer, MD
Founder & Director, Massachusetts General Hospital Bone Density Center

Dr. Neer is a member of the Endocrine Unit at Massachusetts General Hospital in Boston, and the founder and director of the Massachusetts General Hospital Bone Density Center. Dr. Neer’s research and clinical work has focused on understanding the bone-building effects of parathyroid hormone. He has been the principal investigator for many osteoporosis-related clinical studies, including for the Phase III trial of Forteo®, Eli Lilly’s injectable PTH therapy, and has authored over 100 articles, chapters and reviews. Dr. Neer is also an Associate Professor of Medicine at Harvard Medical School. He received his MD from Columbia College of Physicians and Surgeons and completed his residency at Yale-New Haven Hospital.

* denotes founder